TERMINAL COMPONENT OF COMPLEMENT C9 IN CSF AND PLASMA OF PATIENTS WITH MS AND ASEPTIC-MENINGITIS

被引:12
作者
HALAWA, I [1 ]
LOLLI, F [1 ]
LINK, H [1 ]
机构
[1] HUDDINGE HOSP,KAROLINSKA INST,DEPT NEUROL,S-14186 STOCKHOLM,SWEDEN
来源
ACTA NEUROLOGICA SCANDINAVICA | 1989年 / 80卷 / 02期
关键词
D O I
10.1111/j.1600-0404.1989.tb03854.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:130 / 135
页数:6
相关论文
共 20 条
[1]  
BIESECKER G, 1980, J IMMUNOL, V124, P1291
[2]   HUMORAL-FACTORS INVOLVED IN IMMUNE PROCESSES IN MULTIPLE-SCLEROSIS AND ALLERGIC ENCEPHALOMYELITIS [J].
CASPARY, EA .
BRITISH MEDICAL BULLETIN, 1977, 33 (01) :50-53
[3]   CEREBROSPINAL-FLUID C9 IN DEMYELINATING DISEASE [J].
COMPSTON, DAS ;
MORGAN, BP ;
OLEESKY, D ;
FIFIELD, R ;
CAMPBELL, AK .
NEUROLOGY, 1986, 36 (11) :1503-1506
[4]   RADIOIMMUNOASSAY OF THE ATTACK COMPLEX OF COMPLEMENT IN SERUM FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FALK, RJ ;
DALMASSO, AP ;
KIM, Y ;
LAM, S ;
MICHAEL, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) :1594-1599
[5]   DETERMINATION OF SERUM C9 LEVEL BY IMMUNODIFFUSION - ELEVATION IN PATIENTS WITH INFECTIOUS OR ALLERGIC SKIN DISEASES [J].
KAWACHITAKAHASH.S ;
TANAKA, K ;
TAKAHASHI, M ;
KAWASHIMA, T ;
SHIMADA, K .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1975, 48 (02) :161-170
[6]   OLIGOCLONAL IGG BANDS IN CEREBROSPINAL-FLUID - PRINCIPLES FOR DEMONSTRATION AND INTERPRETATION BASED ON FINDINGS IN 1114 NEUROLOGICAL PATIENTS [J].
KOSTULAS, VK ;
LINK, H ;
LEFVERT, AK .
ARCHIVES OF NEUROLOGY, 1987, 44 (10) :1041-1044
[7]   IGG PRODUCTION WITHIN THE CENTRAL NERVOUS-SYSTEM - A CRITICAL-REVIEW OF PROPOSED FORMULAS [J].
LEFVERT, AK ;
LINK, H .
ANNALS OF NEUROLOGY, 1985, 17 (01) :13-19
[8]   COMPLEMENT FACTORS IN MULTIPLE-SCLEROSIS [J].
LINK, H .
ACTA NEUROLOGICA SCANDINAVICA, 1972, 48 (05) :521-&
[9]   INTRATHECAL COMPLEMENT ACTIVATION IN NEUROLOGICAL DISEASES EVALUATED BY ANALYSIS OF THE TERMINAL COMPLEMENT COMPLEX [J].
MOLLNES, TE ;
VANDVIK, B ;
LEA, T ;
VARTDAL, F .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1987, 78 (01) :17-28
[10]  
MOLLNES TE, 1988, CLIN EXP IMMUNOL, V73, P484